Challenges and scientific progress took center stage at the World Health Summit in Berlin, the UN adopted a new pandemic preparedness declaration, concerns continue over the proposed US-funded ...
The US National Institutes of Health (NIH) said its HIV clinical trial networks should “temporarily hold off on launching new studies that had not yet enrolled participants and that would not be ...
This Financial Times webinar, hosted in partnership with ViiV Healthcare, will bring together policymakers, funders, researchers, philanthropies and industry leaders to explore how to keep medical ...
The term autonomous means that a person can make his or her own decisions about what to do and what to agree to. Researchers must respect that individuals should make their own informed decisions ...
In July, Merck announced licensing agreements with seven manufacturers for generic production of its HIV drug alimatravir, though access and equity concerns remain. As AVAC’s Executive Director ...
The US fiscal year ended this week amid questions about the billion dollars in Congressionally-appropriated foreign assistance, while new strategies for HIV research at the National Institutes of ...
Objective:A double-blinded, randomized, placebo-controlled phase II trial to assess extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women The CAPRISA 012C ...
New York City, September 12, 2024 – AVAC welcomes the groundbreaking results of the PURPOSE 2 HIV prevention study of twice-yearly injectable lenacapavir for PrEP among 3,200 cisgender men, ...
The stop-work orders have disrupted USAID-supported HIV prevention research, halting critical investigations in vaccine and next-generation PrEP strategies. The abrupt suspension of these trials also ...
The 2026 US HIV Cure Academy brought skilled advocates and leading HIV cure researchers together for three days of learning and engagement. “We may not have a cure, but one thing is sure, we have the ...
New York City, June 20, 2024 – AVAC welcomes the groundbreaking results of the PURPOSE 1 HIV prevention study among adolescent girls and young women in South Africa and Uganda. Preliminary safety and ...
Artificial intelligence (AI) is rapidly reshaping global health, from disease surveillance to drug and diagnostic discovery and development to the delivery of information, products and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results